{"id":968882,"date":"2026-06-01T06:32:15","date_gmt":"2026-06-01T10:32:15","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/"},"modified":"2026-06-01T06:32:15","modified_gmt":"2026-06-01T10:32:15","slug":"euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/","title":{"rendered":"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask"},"content":{"rendered":"
\n

\n SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) — <\/strong>EUDA Health Holdings Limited (NASDAQ: EUDA) (\u201cEUDA\u201d or the \u201cCompany\u201d), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helix\u00e9 product line with the launch of the Regenix\u00e9 iPSC-derived Skin Stem Cell Secretome Mask (\u201cRegenix\u00e9 Mask\u201d), a beauty product developed by Chemokine Pte Ltd (\u201cChemokine\u201d).<\/p>\n

EUDA holds the exclusive global distributorship rights for Helix\u00e9 products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on molecular supplements and gene-modulating formulations.<\/p>\n

Regenix\u00e9 Mask is formulated with iPSC-derived skin stem cell secretome technology and cellulose mask technology designed to support skin hydration, brightening, and overall recovery. EUDA believes secretome-based skincare products represent a growing category within the premium beauty and wellness market. According to Mordor Intelligence\u2019s Face Mask Market Report, the global face mask market is estimated to be approximately US$7.95 billion in 2026 and is forecast to reach approximately US$9.08 billion by 2031, driven by growing consumer demand for skincare, beauty, and wellness products. Asia-Pacific remains one of the largest regions for facial masks and skincare products, led by demand from China, South Korea, Japan, and Southeast Asia.<\/p>\n

EUDA intends to leverage its established distribution networks and regional wellness partnerships in Malaysia and China to drive sales and distribution of the Regenix\u00e9 Mask and expand the broader Helix\u00e9 product line across the Asia-Pacific region.<\/p>\n

\n About EUDA Health Holdings Limited<\/b>\n <\/p>\n

EUDA Health Holdings Limited (NASDAQ: EUDA) is a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China. The Company aims to become a market leader in non-invasive and preventive healthcare, with a strategic focus on the fast-growing longevity sector. Our mission is to address the evolving healthcare needs of over approximately 1.8 billion people across the region which are experiencing significant demographic shifts as more than approximately 30% of the population ages rapidly. \u00a0EUDA believes that by offering innovative, accessible, and science-backed health solutions, it is positioned to lead the transformation of regional healthcare from reactive medical treatment to proactive, longevity-focused care. EUDA also runs a Singapore-based property management business.<\/p>\n

\n Forward-Looking Statements<\/b>\n <\/p>\n

Certain statements in this press release that are not historical facts constitute \u201cforward-looking statements\u201d within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended. Any statements that refer to expectations or other characterizations of future events, circumstances or results are forward-looking statements. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements. The factors may include, but not be limited to, factors related to the Company\u2019s anticipated growth strategies, future business development, ability to develop new products, expand to other related industries or markets, and other information detailed from time to time in the filings and future filings with the United States Securities and Exchange Commission.\u00a0 The views expressed are those of management and are based on currently available information. Estimates and projections contained herein have been prepared by management and involve significant elements of subjective judgment and analysis and are based on certain assumptions. No representation nor warranty, expressed or implied, is made as to the accuracy or completeness of the information contained in this document, and nothing contained herein is, or shall be relied upon, as a promise or representation, whether as to the past or the future. You are cautioned not to place undue reliance on these forward-looking statements.<\/p>\n

This press release is intended solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy the Company\u2019s stock. This press release is based upon information available to the public, as well as other information from sources which management believes to be\u00a0reliable, but\u00a0is not guaranteed by the Company as being accurate nor does it purport to be complete. Opinions expressed herein are those of management as of the date of publication and are subject to change without notice.\u00a0 Except for ongoing obligations of the Company to disclose material information under the federal securities laws, the Company does not undertake any obligation to release any revisions to any forward-looking statements, to report events or to report the occurrence of unanticipated events.<\/p>\n

Christensen Advisory
Christian Arnell
Phone: + 852 9040 0621
Email:\u00a0christian.arnell@christensencomms.com<\/a><\/p>\n

\"\"
\n
\n \"\"\n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (\u201cEUDA\u201d or the \u201cCompany\u201d), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helix\u00e9 product line with the launch of the Regenix\u00e9 iPSC-derived Skin Stem Cell Secretome Mask (\u201cRegenix\u00e9 Mask\u201d), a beauty product developed by Chemokine Pte Ltd (\u201cChemokine\u201d). EUDA holds the exclusive global distributorship rights for Helix\u00e9 products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on molecular supplements and gene-modulating formulations. Regenix\u00e9 Mask is formulated with iPSC-derived skin stem cell secretome technology and cellulose mask technology designed to support skin hydration, brightening, … <\/p>\n

Continue reading “EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-968882","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (\u201cEUDA\u201d or the \u201cCompany\u201d), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helix\u00e9 product line with the launch of the Regenix\u00e9 iPSC-derived Skin Stem Cell Secretome Mask (\u201cRegenix\u00e9 Mask\u201d), a beauty product developed by Chemokine Pte Ltd (\u201cChemokine\u201d). EUDA holds the exclusive global distributorship rights for Helix\u00e9 products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on molecular supplements and gene-modulating formulations. Regenix\u00e9 Mask is formulated with iPSC-derived skin stem cell secretome technology and cellulose mask technology designed to support skin hydration, brightening, … Continue reading "EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2026-06-01T10:32:15+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask\",\"datePublished\":\"2026-06-01T10:32:15+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/\"},\"wordCount\":757,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/\",\"name\":\"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==\",\"datePublished\":\"2026-06-01T10:32:15+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/","og_locale":"en_US","og_type":"article","og_title":"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask - Market Newsdesk","og_description":"SINGAPORE, June 01, 2026 (GLOBE NEWSWIRE) — EUDA Health Holdings Limited (NASDAQ: EUDA) (\u201cEUDA\u201d or the \u201cCompany\u201d), a Singapore-based non-invasive healthcare provider in Asia with a focus on Singapore, Malaysia and China, today announced it is expanding the Helix\u00e9 product line with the launch of the Regenix\u00e9 iPSC-derived Skin Stem Cell Secretome Mask (\u201cRegenix\u00e9 Mask\u201d), a beauty product developed by Chemokine Pte Ltd (\u201cChemokine\u201d). EUDA holds the exclusive global distributorship rights for Helix\u00e9 products, that includes but is not limited to, a next-generation immune health supplement, from Chemokine, a Singapore-based biotech company focused on molecular supplements and gene-modulating formulations. Regenix\u00e9 Mask is formulated with iPSC-derived skin stem cell secretome technology and cellulose mask technology designed to support skin hydration, brightening, … Continue reading \"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/","og_site_name":"Market Newsdesk","article_published_time":"2026-06-01T10:32:15+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask","datePublished":"2026-06-01T10:32:15+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/"},"wordCount":757,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/","name":"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==","datePublished":"2026-06-01T10:32:15+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTcyOTU1OSM3NjMwMDMxIzUwMDEyNDQzOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/euda-health-expands-helixe-product-line-with-launch-of-regenixe-ipsc-derived-skin-stem-cell-secretome-mask\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"EUDA Health Expands Helix\u00e9 Product Line with Launch of Regenix\u00e9 iPSC-Derived Skin Stem Cell Secretome Mask"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968882","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=968882"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/968882\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=968882"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=968882"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=968882"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}